Future therapeutics aimed at augmenting the anti-inflammatory effect through Nurr1 activation could mitigate the toxic environment, modulate neuroinflammation and foster the MN repair process, having a positive effect on ALS treatment. Here, NR4A2 is linked to amyotrophic lateral sclerosis.